Cancer is scary for many reasons. Investing in companies that make diagnostics or therapeutics for cancer can be equally scary. This first of a three part series helps to clear up some of the complexities of cancer to make investing in this industry a little easier.
January 14, 2022
– Advisor: Dana Abramovitz